Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Northwest Biotherapeutics (NWBO) Consolidated Net Income (2016 - 2025)

Historic Consolidated Net Income for Northwest Biotherapeutics (NWBO) over the last 17 years, with Q3 2025 value amounting to -$16.9 million.

  • Northwest Biotherapeutics' Consolidated Net Income fell 35.54% to -$16.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$73.4 million, marking a year-over-year decrease of 541.68%. This contributed to the annual value of -$74.3 million for FY2024, which is 2226.54% down from last year.
  • Per Northwest Biotherapeutics' latest filing, its Consolidated Net Income stood at -$16.9 million for Q3 2025, which was down 35.54% from -$16.6 million recorded in Q2 2025.
  • Northwest Biotherapeutics' 5-year Consolidated Net Income high stood at -$11.7 million for Q3 2021, and its period low was -$22.5 million during Q2 2022.
  • Over the past 5 years, Northwest Biotherapeutics' median Consolidated Net Income value was -$16.9 million (recorded in 2024), while the average stood at -$16.8 million.
  • Within the past 5 years, the most significant YoY rise in Northwest Biotherapeutics' Consolidated Net Income was 7818.48% (2021), while the steepest drop was 14848.66% (2021).
  • Over the past 5 years, Northwest Biotherapeutics' Consolidated Net Income (Quarter) stood at -$11.8 million in 2021, then crashed by 64.0% to -$19.4 million in 2022, then grew by 15.54% to -$16.4 million in 2023, then decreased by 28.09% to -$21.0 million in 2024, then rose by 19.28% to -$16.9 million in 2025.
  • Its Consolidated Net Income was -$16.9 million in Q3 2025, compared to -$16.6 million in Q2 2025 and -$18.9 million in Q1 2025.